Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Robert Clifton Yates net worth and biography

Robert Yates Biography and Net Worth

Director of Ortho Clinical Diagnostics

Mr. Robert Yates is the Director of Ortho Clinical Diagnostics.

What is Robert Clifton Yates' net worth?: The estimated net worth of Robert Clifton Yates is at least $6.12 million as of August 4th, 2021. Mr. Yates owns 346,942 shares of Ortho Clinical Diagnostics stock worth more than $6,116,587 as of April 18th. This net worth estimate does not reflect any other assets that Mr. Yates may own. Learn More about Robert Clifton Yates' net worth.
How do I contact Robert Clifton Yates?: The corporate mailing address for Mr. Yates and other Ortho Clinical Diagnostics executives is 1001 ROUTE 202, RARITAN NJ, 08869. Ortho Clinical Diagnostics can also be reached via phone at 908-218-8000 and via email at [email protected]. Learn More on Robert Clifton Yates' contact information.
Has Robert Clifton Yates been buying or selling shares of Ortho Clinical Diagnostics?: Robert Clifton Yates has not been actively trading shares of Ortho Clinical Diagnostics during the past quarter. Most recently, Robert Clifton Yates sold 140,042 shares of the business's stock in a transaction on Wednesday, August 4th. The shares were sold at an average price of $21.79, for a transaction totalling $3,051,515.18. Following the completion of the sale, the director now directly owns 346,942 shares of the company's stock, valued at $7,559,866.18. Learn More on Robert Clifton Yates' trading history.
Who are Ortho Clinical Diagnostics' active insiders?: Ortho Clinical Diagnostics' insider roster includes Michael Schlesinger (EVP), Christopher Smith (CEO), and Robert Yates (Director). Learn More on Ortho Clinical Diagnostics' active insiders.

Robert Clifton Yates Insider Trading History at Ortho Clinical Diagnostics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/4/2021	Sell	140,042	$21.79	$3,051,515.18	346,942
8/2/2021	Sell	25,551	$22.06	$563,655.06	346,942

Robert Clifton Yates Buying and Selling Activity at Ortho Clinical Diagnostics

Ortho Clinical Diagnostics Company Overview

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Today's Range

Now: $17.63

$17.63

50 Day Range

MA: $17.63

$17.63

2 Week Range

Now: $17.63

$16.04

$22.99

Volume

5,400 shs

Average Volume

1,240,588 shs

Market Capitalization

$3.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32